Feedback logo

FDBK - Feedback Share Price

1.05p -0.1  -6.7%

Last Trade - 22/05/20

Micro Cap
Market Cap £5.67m
Enterprise Value £4.14m
Revenue £596k
Position in Universe 1600th / 1827
Unlock FDBK Revenue
Relative Strength (%)
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Financial Summary
FINANCIAL BRIEF: : For the six months ended 30 November 2019, Feedback plc revenues increased 14% to £269K. Net loss increased 63% to £603K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Other Operating Expenses increase of 49% to £956K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


FDBK Revenue Unlock FDBK Revenue

Net Income

FDBK Net Income Unlock FDBK Revenue

Normalised EPS

FDBK Normalised EPS Unlock FDBK Revenue

PE Ratio Range

FDBK PE Ratio Range Unlock FDBK Revenue

Dividend Yield Range

FDBK Dividend Yield Range Unlock FDBK Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
FDBK EPS Forecasts Unlock FDBK Revenue
Profile Summary

Feedback plc is a United Kingdom-based medical imaging software company. The Company is engaged in providing imaging tools for clinical decision makers. The Company is engaged in developing techniques and managing workflow for medical practitioners involved in research and in treating patients. The Company offers TexRAD, which is engaged in providing medical research and it can be used to manage clinical trials and helps to manage pharmaceuticals. The Company is engaged in identifying imaging biomarkers that can be used in detection of cancer. It offers Cadran, a medical imaging tools for decision support. Cadran Image Storage Management offers fully featured image display, review and manipulation options and enterprise archiving for clinical, non-clinical and teaching use. The Company's subsidiaries include Feedback Black Box Company Limited, Feedback Data GmbH, Brickshield Limited, Cambridge Computed Imaging Limited, TexRAD Limited and Prostate Checker Ltd.

Last Annual May 31st, 2019
Last Interim November 30th, 2019
Incorporated February 11, 1958
Public Since January 8, 1986
No. of Shareholders: n/a
No. of Employees: 25
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 539,949,917
Free Float (0.0%)
Eligible for
FDBK Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for FDBK
Upcoming Events for FDBK
Similar to FDBK
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.